Status:
COMPLETED
Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)
Lead Sponsor:
Biotronik SE & Co. KG
Conditions:
Tachyarrhythmia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A unique single-lead dual-chamber implantable cardioverter-defibrillator (ICD) system (produced by Biotronik, Germany) features a conventional electrode in the ventricle (anchored in the ventricular a...
Detailed Description
Supraventricular tachyarrhythmia (SVT) is the main cause of inappropriate therapy in patients with single-chamber implantable cardioverter-defibrillators (ICDs). To minimize inappropriate shock delive...
Eligibility Criteria
Inclusion
- ICD indication according to American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
- Informed consent
Exclusion
- Permanent atrial fibrillation
- Requirement for atrial pacing
- Patient is underage
- No signed patient agreement
- Patient life expectancy under 6 months
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT00324662
Start Date
August 1 2003
End Date
July 1 2008
Last Update
September 30 2008
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Sana Klinikum Lichtenberg
Berlin, Germany, 10365
2
Charité-Universitätsmedizin Campus Benjamin Franklin, Med. Klinik II / Kardiologie
Berlin, Germany, 12200
3
Vivantes Netzwerk für Gesundheit GmbH (Humboldt)
Berlin, Germany, 13437
4
Kardiologische Praxis
Bonn, Germany, 53115